BIOASTER
Oxana Vratskikh is a research manager at BIOASTER since January 2021, bringing extensive expertise in immunology and virology. Previously, Vratskikh served as a postdoctoral researcher at Institut Pasteur from June 2014 to December 2020, focusing on the development of multiplex detection assays for viral hemorrhagic fevers and coronaviruses, as well as investigating the human antibody response to Chikungunya virus infection. Key activities included FACS isolation, single cell cloning of human memory B cells' IgG antibodies, and the design and production of recombinant chimeric antibodies and viral antigens. Vratskikh holds a PhD in Immunology and Virology from the Medical University of Vienna and a Master's degree in Molecular Biology from Novosibirsk State University. Additionally, Vratskikh is currently pursuing a DU GBM in "Valorisation de la recherche et l'innovation biomedicale" at Pierre and Marie Curie University.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org